Boston Trust Walden Corp Cooper Companies, Inc. Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$306.88 - $380.0 $18.8 Million - $23.2 Million	61,117 Added 21.68%	343,033 $130 Million
Q3 2023 Oct 18, 2023	BUY	$315.92 - $397.36 $329,188 - $414,049	1,042 Added 0.37%	281,916 $89.7 Million
Q2 2023 Jul 24, 2023	SELL	$346.15 - $392.09 $6.3 Million - $7.13 Million	-18,193 Reduced 6.08%	280,874 $108 Million
Q1 2023 Apr 19, 2023	SELL	$323.56 - $373.36 $6.61 Million - $7.63 Million	-20,437 Reduced 6.4%	299,067 $112 Million
Q4 2022 Jan 20, 2023	BUY	$248.67 - $334.17 $9.14 Million - $12.3 Million	36,756 Added 13.0%	319,504 $0
Q3 2022 Oct 19, 2022	BUY	$263.81 - $337.27 $12.7 Million - $16.3 Million	48,184 Added 20.54%	282,748 $74.6 Million
Q2 2022 Jul 22, 2022	BUY	$301.4 - $428.42 $5.29 Million - $7.52 Million	17,564 Added 8.09%	234,564 $73.4 Million
Q1 2022 Apr 20, 2022	BUY	$379.46 - $424.54 $6.4 Million - $7.16 Million	16,864 Added 8.43%	217,000 $90.6 Million
Q4 2021 Jan 21, 2022	SELL	$373.53 - $434.12 $99,358 - $115,475	-266 Reduced 0.13%	200,136 $83.8 Million
Q3 2021 Oct 25, 2021	BUY	$396.76 - $455.92 $2.62 Million - $3.01 Million	6,601 Added 3.41%	200,402 $82.8 Million
Q2 2021 Jul 22, 2021	BUY	$372.36 - $412.07 $3.11 Million - $3.45 Million	8,363 Added 4.51%	193,801 $76.8 Million
Q1 2021 Apr 21, 2021	BUY	$357.26 - $392.57 $6.38 Million - $7.01 Million	17,866 Added 10.66%	185,438 $71.2 Million
Q4 2020 Jan 15, 2021	BUY	$319.05 - $363.32 $5.85 Million - $6.66 Million	18,325 Added 12.28%	167,572 $60.9 Million
Q3 2020 Oct 14, 2020	BUY	$280.08 - $347.78 $2.87 Million - $3.56 Million	10,235 Added 7.36%	149,247 $50.3 Million
Q2 2020 Jul 23, 2020	BUY	$270.93 - $320.3 $651,857 - $770,641	2,406 Added 1.76%	139,012 $39.4 Million
Q1 2020 Apr 24, 2020	SELL	$243.44 - $359.98 $1.63 Million - $2.41 Million	-6,691 Reduced 4.67%	136,606 $37.7 Million
Q1 2020 Apr 21, 2020	BUY	$243.44 - $359.98 $18.4 Million - $27.2 Million	75,597 Added 111.66%	143,297 $39.5 Million
Q4 2019 Jan 10, 2020	BUY	$281.18 - $322.05 $501,343 - $574,215	1,783 Added 2.7%	67,700 $21.8 Million
Q3 2019 Oct 21, 2019	BUY	$294.25 - $341.49 $1.6 Million - $1.86 Million	5,441 Added 9.0%	65,917 $19.6 Million
Q2 2019 Jul 25, 2019	SELL	$279.29 - $336.89 $100,823 - $121,617	-361 Reduced 0.59%	60,476 $20.4 Million
Q1 2019 Apr 16, 2019	BUY	$246.18 - $297.25 $501,961 - $606,092	2,039 Added 3.47%	60,837 $18 Million
Q4 2018 Jan 17, 2019	BUY	$232.7 - $281.66 $1.12 Million - $1.36 Million	4,834 Added 8.96%	58,798 $15 Million
Q3 2018 Oct 23, 2018	BUY	$236.3 - $277.15 $39,698 - $46,561	168 Added 0.31%	53,964 $15 Million
Q2 2018 Jul 25, 2018	BUY	$217.98 - $237.23 $702,985 - $765,066	3,225 Added 6.38%	53,796 $12.7 Million
Q1 2018 Apr 13, 2018	BUY	$218.74 - $251.43 $73,277 - $84,229	335 Added 0.67%	50,571 $11.6 Million
Q4 2017 Jan 29, 2018	BUY	$217.88 - $244.43 $439,028 - $492,526	2,015 Added 4.18%	50,236 $10.9 Million
Q3 2017 Oct 13, 2017	BUY	$231.6 - $253.39 $11.2 Million - $12.2 Million	48,221	48,221 $11.4 Million

Others Institutions Holding COO

# of Institutions

Shares Held

1.59M

Call Options Held

Put Options Held

Intermede Investment Partners LTD

1.09M
Shares

$109 Million
2.52% of portfolio
Pictet Asset Management Sa Geneva 73, V8

143K
Shares

$14.2 Million
0.07% of portfolio
Brant Point Investment Management LLC New York, NY

109K
Shares

$10.9 Million
2.96% of portfolio
Eaton Vance Management Boston, MA

86.1K
Shares

$8.58 Million
0.03% of portfolio
Crystal Rock Capital Management

54.2K
Shares

$5.4 Million
3.65% of portfolio

View Full List

About COOPER COMPANIES, INC.

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

More about COO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account